Johnson & Johnson Navigates Tariff Turbulence with Strong Earnings and Bold Future Investments April 16, 2025
Johnson & Johnson Navigates Tariff Challenges with Strong Financial Projections and Domestic Investment Plans April 15, 2025
Johnson & Johnson Navigates Tariff Turmoil with Steady Earnings Outlook and Bold U.S. Investment Plans April 15, 2025
Biden Administration Launches Investigation into Pharmaceutical Imports, Paving the Way for New Tariffs and Domestic Manufacturing Investments April 15, 2025
Commerce Department Launches Investigation into Pharmaceutical Imports, Paving the Way for Tariffs and Domestic Manufacturing Boost April 15, 2025
Biden Administration Launches Investigation into Pharmaceutical Imports: Aiming for National Security and Domestic Manufacturing Revival April 15, 2025
Pfizer Halts Danuglipron Development: A Setback in the Race for Oral Obesity Treatments April 14, 2025
Pfizer Halts Danuglipron Development, Intensifying Competition in the Obesity Drug Market April 14, 2025
Unlocking Patient Insights: Harnessing Unstructured EMR Data to Transform Pharmaceutical Strategies April 14, 2025
